HMOX1 and colitis: Moreover, rectally administered TRL ameliorated colonic damage and inflammation in rats with DNBS-induced colitis, which was partly compromised by chemical reduction of TRL (removing electrophilicity) or co-treatment with an HO-1 inhibitor.